SCHEMBL6134210

SCHEMBL6134210

NNC(=O)c1ccc(N2CCN(C3CCC4(CC3)OCCO4)CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ITGB3 P05106 1/20 0.45
ITGA2B P08514 1/20 0.45
ALOX15 P16050 1/20 0.44
HRH3 Q9Y5N1 2/20 0.43
L3MBTL3 Q96JM7 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
PARP1 P09874 1/20 0.41
MBTD1 Q05BQ5 1/20 0.41
TP53BP1 Q12888 1/20 0.41
L3MBTL4 Q8NA19 1/20 0.41
POLB P06746 1/20 0.40
HDAC3 O15379 4/20 0.40
HDAC8 Q9BY41 4/20 0.40
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40
JAK3 P52333 1/20 0.40
SMYD3 Q9H7B4 2/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6135046 0.89 KMT2A (0.46) MEN1KMT2AITGB3ITGA2BALOX15
SCHEMBL6135305 0.85 HRH3 (0.51) MEN1KMT2AITGB3ITGA2BALOX15
SCHEMBL6134959 0.85 POLB (0.50) L3MBTL1POLBHDAC3HDAC8SMYD3
SCHEMBL6134440 0.84 KMT2A (0.45) MEN1KMT2AALOX15L3MBTL3L3MBTL1
SCHEMBL6134717 0.82 ITGB3 (0.52) MEN1KMT2AITGB3ITGA2BALOX15
SCHEMBL6134192 0.81 ITGB3 (0.51) MEN1KMT2AITGB3ITGA2BALOX15
SCHEMBL6134434 0.81 ALDH1A1 (0.49) MEN1KMT2APOLBMAPT
SCHEMBL6132283 0.79 MEN1 (0.55) MEN1KMT2AITGB3ITGA2BALOX15
SCHEMBL6265731 0.77 L3MBTL3 (0.46) MEN1KMT2AL3MBTL3L3MBTL1MAPT
SCHEMBL3085835 0.76 AOC2 (0.59) MEN1KMT2AITGB3ITGA2BL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261177-A1 Compound ASTELLAS PHARMA INC. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261177-A1 Compound MANBA, MAN2B1, MAN2A1 MEN1 880/4885KMT2A 4492/4885ITGB3 1732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.